(Q56778528)

English

Baseline HIV Type 1 Genotypic Resistance to a Newly Added Nucleoside Analog Is Predictive of Virologic Failure of the New Therapy

article

  • Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy

Statements

Baseline HIV Type 1 Genotypic Resistance to a Newly Added Nucleoside Analog Is Predictive of Virologic Failure of the New Therapy (English)
0 references
Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy (English)
0 references
0 references
0 references
0 references
A.-M. Vandamme
A M Vandamme
0 references
0 references
K. Van Vaerenbergh
0 references
K. Van Laethem
0 references
E. Van Wijngaerden
0 references
J.-C. Schmit
0 references
F. Schneider
0 references
L. Ruiz
0 references
C. Verhofstede
0 references
F. Van Wanzeele
0 references
G. M Uyldermans
0 references
P. Simons
0 references
L. Stuyver
0 references
P. Hermans
0 references
C. Evans
0 references
E. De Clercq
0 references
J. Desmyter
0 references
G Muyldermans
0 references
April 2000
0 references
10 April 2000
0 references
16
0 references
6
0 references
529-537
0 references
529-37
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit